DEUTSCHE BANK AG\ - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 87 filers reported holding KARUNA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,722,338
-9.2%
51,584
+16.4%
0.01%
+20.0%
Q2 2023$9,606,889
-26.7%
44,302
-38.6%
0.01%
-28.6%
Q1 2023$13,111,865
-8.6%
72,186
-1.1%
0.01%
-12.5%
Q4 2022$14,348,234
-9.3%
73,019
+3.8%
0.01%
-20.0%
Q3 2022$15,819,000
+149.0%
70,331
+40.1%
0.01%
+150.0%
Q2 2022$6,352,000
+12.0%
50,205
+12.3%
0.00%
+33.3%
Q1 2022$5,670,000
-6.0%
44,718
-2.9%
0.00%0.0%
Q4 2021$6,032,000
+4.8%
46,043
-2.2%
0.00%0.0%
Q3 2021$5,757,000
-1.8%
47,068
-8.5%
0.00%0.0%
Q2 2021$5,861,000
+1.3%
51,420
+6.9%
0.00%0.0%
Q1 2021$5,783,000
-28.4%
48,104
-39.5%
0.00%
-40.0%
Q4 2020$8,075,000
+39.1%
79,479
+5.9%
0.01%
+25.0%
Q3 2020$5,804,000
-29.9%
75,062
+1.0%
0.00%
-33.3%
Q2 2020$8,283,000
+49.0%
74,308
-3.7%
0.01%
+20.0%
Q1 2020$5,559,000
-9.6%
77,198
-5.5%
0.01%
+25.0%
Q4 2019$6,152,000
+637.6%
81,680
+59.3%
0.00%
+300.0%
Q3 2019$834,00051,2620.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 908,708$109,254,00035.05%
Sofinnova Investments, Inc. 1,952,441$234,742,00014.11%
Logos Global Management LP 200,000$24,046,0002.35%
First Light Asset Management, LLC 258,500$31,079,0002.06%
Eventide Asset Management 971,077$116,753,0001.73%
DAFNA Capital Management LLC 48,000$5,771,0001.37%
CATALYST PRIVATE WEALTH, LLC 13,006$1,564,0001.10%
Rock Springs Capital Management LP 368,764$44,336,0000.97%
Pinz Capital Management, LP 28,805$3,463,0000.92%
MILLER VALUE PARTNERS, LLC 291,239$35,016,0000.91%
View complete list of KARUNA THERAPEUTICS INC shareholders